A prospective study of hepatitis C virus infection in renal allograft recipients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Transplantation

• Publication date

  1996-03-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199603270-00007PMID 8623154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variability of hepatitis C virus

  1995cited by this paper
• Clinical outcomes after transfusion-associated hepatitis C.

  1995cited by this paper
• Hepatitis C virus: the nephrologist's view.

  1995cited by this paper
• Hepatitis C Genotypes: The Key to Pathogenicity?

  1995cited by this paper
• Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only.

  1994cited by this paper
• The impact of hepatitis C virus infection on renal allograft recipients.

  1994cited by this paper
• Degree of diversity of hepatitis C virus quasispecies and progression of liver disease

  1994cited by this paper
• Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection.

  1994cited by this paper
• Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients.

  1993cited by this paper
• Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

  1993cited by this paper
• Hepatitis C virus infection in kidney transplant recipients

  1993cited by this paper
• HEPATITIS C—ITS PREVALENCE IN END‐STAGE RENAL FAILURE PATIENTS AND CLINICAL COURSE AFTER KIDNEY TRANSPLANTATION

  1993cited by this paper
• Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade

  1993cited by this paper
• Clinical implications of the presence of antibodies to hepatitis C after renal transplantation.

  1992cited by this paper
• Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation.

  1992cited by this paper
• Hepatitis C antibody in renal transplant patients.

  1992cited by this paper
• Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis

  1992cited by this paper
• The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients.

  1992cited by this paper
• Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.

  1992cited by this paper
• Hepatitis C virus infection among kidney transplant recipients.

  1991cited by this paper
• Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation

  1991cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

  1990cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

  1989cited by this paper
• Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

  1989cited by this paper
• Long-term results and complications in renal transplant recipients. Observations in the second decade.

  1988cited by this paper
• Liver disease in recipients of long-functioning renal allografts.

  1985cited by this paper
• LATE MORTALITY AND MORBIDITY IN RECIPIENTS OF LONG‐TERM RENAL ALLOGRAFTS

  1982cited by this paper

• HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels

  2022cites this paper
• Changing pattern of chronic hepatitis C in renal transplant patients over 20 years.

  2019cites this paper
• Management and treatment of the HCV‐infected kidney transplant patient

  2018cites this paper
• The Impact of Hepatitis C Virus Infection on the Clinical Course, Short Term and Long–Term Outcome in Renal Transplant Recipients–A Prospective and Retrospective Study

  2017cites this paper
• Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus

  2017influential citation
• Treating Hepatitis C Infection in Patients With Chronic Kidney Disease: Our Options Have Improved Greatly

  2017cites this paper
• Use of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Virus Infection in the Perspective of Kidney Transplantation

  2017cites this paper
• Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

  2016cites this paper
• Lack of impact of hepatitis C virus infection on graft survival after kidney transplantation--a Portuguese single-center experience.

  2015cites this paper
• Novel Hepatitis C Treatment and the Impact on Kidney Transplantation.

  2015cites this paper
• Hepatitis C and its impact on renal transplantation

  2015cites this paper
• Management of hepatitis C in patients with chronic kidney disease.

  2015cites this paper
• Hepatitis C Infection in Kidney Transplantion

  2013cites this paper
• Campath induction in HCV and HCV/HIV‐seropositive kidney transplant recipients

  2013cites this paper
• Time of acquisition of HCV infection in renal transplant recipients: a major prognostic factor for disease progression

  2013cites this paper
• Histological evolution of hepatitis C virus infection after renal transplantation

  2012cites this paper
• Inauspicious contribution of hepatitis C virus and diabetes mellitus targeting kidneys: an update.

  2012cites this paper
• The influence of induction therapy for kidney transplantation after a non-renal transplant.

  2012cites this paper
• Treatment of hepatitis C virus infection after kidney transplantation.

  2012cites this paper
• Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.

  2012cites this paper
• Treatment issues surrounding hepatitis C in renal transplantation: a review.

  2011cites this paper
• Dilemma of HCV Infection in Renal Transplant Recipients

  2011cites this paper
• Dilemma of HCV Infection in Renal Transplant Recipients

  2011cites this paper
• Hepatitis C virus and kidney: a strong association with different clinical aspects

  2011cites this paper
• Successful Treatment of Hepatitis C Virus in a Renal Transplant Recipient; Case Report and Review of the Current Literature

  2010cites this paper
• Kidney grafts from HCV-positive donors: advantages and disadvantages.

  2010cites this paper
• Influence of Preexisting Hepatitis C Virus Antibody Positivity in Simultaneous Pancreas-Kidney Transplant Recipients

  2010cites this paper
• Impact of hemodialysis therapy on hepatitis C virus infection: a deeper insight.

  2009cites this paper
• Impact of Hemodialysis Therapy on Hepatitis C Virus Infection: A Deeper Insight

  2009cites this paper
• Transplantation in the patient with hepatitis C

  2009cites this paper
• Impact of Immunosuppressive Regimen on Survival of Kidney Transplant Recipients With Hepatitis C

  2008cites this paper
• Patient and graft survival of kidney allograft recipients with minimal hepatitis C virus infection: a case-control study.

  2008cites this paper
• [Chronic viral hepatitis and kidney failure].

  2008cites this paper
• Hepatitis C and renal transplantation: a review on historical aspects and current issues

  2008influential citation
• Hepatitis C virus infection in haemodialysis and kidney transplant patients

  2008cites this paper
• Hepatitis C Virus Infection and Kidney Transplantation: Predictors of Patient and Graft Survival

  2007cites this paper
• Clinical course of hepatitis C virus infection in renal transplant recipients.

  2007cites this paper
• Immunology of HCV and HBV in Renal Failure and Transplantation

  2007cites this paper
• Influence of Pretransplant IFN-Alpha Therapy on Interstitial Fibrosis in Renal Allografts with Hepatitis C Virus Infection

  2007cites this paper
• The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.

  2006cites this paper
• Is Hepatitis C More Aggressive in Renal Transplant Patients Than in Patients With End-Stage Renal Disease?

  2006cites this paper
• Hepatits B and C Treatment in Renal Transplanted Patient

  2006cites this paper
• Hepatitis C virus infection in renal transplant patients: a comparative study with immunocompetent patients

  2005cites this paper
• Ribavirin monotherapy for Hepatitis C virus infection in renal transplant recipient

  2005cites this paper
• Hepatitis C Virus Antibody Status and Survival After Renal Transplantation: Meta‐Analysis of Observational Studies

  2005cites this paper
• Interferon Therapy in Hemodialysis Patients with Chronic Hepatitis C: Study of Tolerance, Efficacy and Post-Transplantation Course

  2005cites this paper
• [Hepatitis C virus infection in renal-transplant patients].

  2004cites this paper
• [Hepatitis C virus and renal transplantation].

  2004cites this paper
• Amantadine therapy in renal transplant patients with hepatitis C virus infection.

  2004cites this paper
• Modification de la virémie du VHC après transplantation rénale

  2004cites this paper
• Renal transplantation offers a better survival in HCV‐infected ESRD patients

  2004cites this paper
• Hépatite virale C et transplantation rénale

  2004cites this paper
• Should patients with chronic hepatitis C infection be transplanted?

  2004cites this paper
• The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study.

  2004cites this paper
• Hepatitis C in chronic kidney disease and kidney transplantation : With special reference to epidemiology and treatment

  2003cites this paper
• [Hepatitis C infection among patients receiving hemodialysis].

  2003cites this paper
• Living related renal transplantation for end‐stage renal disease after liver transplantation from a brain‐dead donor

  2003cites this paper
• Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis

  2003cites this paper
• Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

  2003cites this paper
• Hepatitis C and renal disease: an update.

  2003cites this paper
• [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?].

  2003cites this paper
• Infection par le virus de l ’ hépatite C en hémodialyse

  2003cites this paper
• HCV antibody positivity significantly affects renal allograft survival.

  2003cites this paper
• Management of chronic viral hepatitis before and after renal transplantation

  2002cites this paper
• Renal Transplantation Update
Series Editors: V. Ram Peddi and M. Roy First: Hepatobiliary Diseases After Kidney Transplantation Unrelated to Classic Hepatitis Virus

  2002cites this paper
• Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation

  2002cites this paper
• Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection.

  2002cites this paper
• Hepatitis C virus in solid organ transplantation: not always a bad thing?

  2002cites this paper
• Hepatitis C virus infection in patients on renal replacement therapy

  2002cites this paper
• Hepatitis C virus infection and kidney transplantation.

  2002cites this paper
• SPECTRUM OF LIVER DAMAGE AND CORRELATION WITH CLINICAL AND LABORATORY PARAMETERS IN HCV INFECTED HEMODIALYSIS PATIENTS

  2001cites this paper
• KIDNEY TRANSPLANTATION FOR END-STAGE RENAL FAILURE IN LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C VIRAL INFECTION1

  2001cites this paper
• Hepatitis B and C and renal failure.

  2001cites this paper
• The Evaluation of the Renal Transplant Candidates: Clinical Practice Guidelines

  2001cites this paper
• Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.

  2001cites this paper
• Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection

  2000cites this paper
• Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil.

  2000cites this paper
• Complex management issues: management of HCV in the atypical patient.

  2000cites this paper
• Effects of hepatitis C virus infection on cyclosporine trough levels in renal transplant patients.

  2000cites this paper
• Treatment of hepatitis C virus infection after renal transplantation: new insights.

  2000cites this paper
• Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients.

  2000cites this paper
• Histopathological features of hepatitis C in renal transplant candidates [see comment].

  2000cites this paper
• 17 Hepatitis C and renal disease

  2000cites this paper
• Pretransplantation alpha-interferon therapy and the effect of hepatitis C virus infection on kidney allograft recipients.

  2000cites this paper
• Transplantation in the patient with hepatitis C.

  2000cites this paper
• Serial measurements of serum transaminases in renal transplant recipients with chronic hepatitis C: do they reflect disease severity?

  2000cites this paper
• Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

  2000cites this paper
• Impact of hepatitis B and C virus on kidney transplantation outcome

  1999cites this paper
• Selected drug complications and treatment conflicts in the presence of coexistent diseases.

  1999cites this paper
• [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].

  1999cites this paper
• Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients.

  1999cites this paper
• Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years.

  1999cites this paper
• Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation

  1999cites this paper
• Hepatitis C virus infection and renal transplantation.

  1999cites this paper
• Hepatitis C virus and renal transplantation

  1998cites this paper
• Hepatitis C and renal transplantation: the controversy continues.

  1998cites this paper
• Hepatitis C virus genotypes and the influence of the induction of immunosuppression with anti‐thymocyte globulin (ATG) on chronic hepatitis in renal graft recipients

  1998cites this paper
• Renal transplantation in patients positive for hepatitis B or C (pro).

  1998cites this paper
• Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.

  1998cites this paper
• Is long-term chronic immunosuppression therapy detrimental in hepatitis C virus-positive renal transplant patients?

  1998cites this paper